216 results on '"Mannent, Leda P."'
Search Results
2. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
3. Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma
4. Dupilumab sustains lung function improvements in patients with moderate-to-severe asthma
5. Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study
6. Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials
7. Nasal brushing molecular endotyping distinguishes patients with chronic rhinosinusitis with nasal polyps with better response to dupilumab
8. Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
9. Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma
10. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis
11. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial
12. Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma: An Analysis of the Phase 3, Open-Label Extension TRAVERSE Trial
13. Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases
14. Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps
15. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
16. Blood eosinophils and FeNO are prognostic and predictive biomarkers in childhood asthma
17. Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE study
18. Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION): an open-label extension study
19. Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps
20. Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma
21. Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate to Severe Atopic Dermatitis
22. Chronic Rhinosinusitis with Nasal Polyps and Asthma
23. Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma
24. Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis
25. Efficacy of dupilumab in patients with uncontrolled, moderate‐to‐severe asthma with fungal sensitization
26. Dupilumab in Asia-Pacific patients with persistent asthma
27. Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results.
28. Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
29. Assessment of the long-term safety and efficacy of dupilumab in children with asthma: LIBERTY ASTHMA EXCURSION
30. Clinical Efficacy among Patients with Chronic Rhinosinusitis with Nasal Polyps and Clinical Features of Obstructive Lung Disease: Post Hoc Analysis of the Phase III SINUS-24 and SINUS-52 Studies
31. Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic oesophagitis: a subgroup analysis of the phase 3 LIBERTY EoE TREET study
32. The relationship of sinus opacification, olfaction and dupilumab efficacy in patients with CRSwNP.
33. 307 The study design of a trial of dupilumab in adult patients with bullous pemphigoid (BP): LIBERTY-BP ADEPT
34. 344 Dupilumab significantly improves itch and skin lesions in patients with prurigo nodularis: pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)
35. Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis
36. sj-docx-1-aor-10.1177_00034894231176334 – Supplemental material for Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results
37. EFFICACY AND SAFETY OF DUPILUMAB FOR COPD WITH TYPE 2 INFLAMMATION
38. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial
39. Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD : results from two randomized placebo‐controlled phase 3 trials
40. Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies
41. Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccines
42. Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
43. Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyposis
44. Dupilumab in CRSwNP : Responder Analysis Using Clinically Meaningful Efficacy Outcome Thresholds
45. Data Mining of Free-Text Responses: An Innovative Approach to Analyzing Patient Perspectives on Treatment for Chronic Rhinosinusitis with Nasal Polyps in a Phase IIa Proof-of-Concept Study for Dupilumab
46. Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID‐ERD: Results from two randomized placebo‐controlled phase 3 trials
47. Dupilumab sustains long-term OCS reduction in OCS-dependent asthma patients
48. Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status
49. 42011 Dupilumab Improves Urticaria Signs and Symptoms and Quality of Life in Patients With Chronic Spontaneous Urticaria (CSU)
50. Dupilumab treatment effects are observed after the first dose as measured at week 2 across atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps: Data from phase 3 SOLO 1 & 2, LIBERTY ASTHMA QUEST, and SINUS-52 studies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.